Jh. Hannigan et Rf. Berman, Amelioration of fetal alcohol-related neurodevelopmental disorders in rats: exploring pharmacological and environmental treatments, NEUROTOX T, 22(1), 2000, pp. 103-111
Fetal alcohol syndrome (FAS) and alcohol-related neurodevelopmental disorde
rs (ARNDs) in children are characterized by life-long compromises in learni
ng, memory, and adaptive responses. Until the advent of effective preventio
n measures, it will remain necessary to seek ways to treat the life-long ne
urobehavioral consequences of prenatal alcohol exposure. To date, there are
no clinical remedies to recommend for either specific or global fetal alco
hol effects. This article reviews our basic research in animal models that
assesses the potential of global environmental manipulations or specific ps
ychopharmacological treatments to ameliorate the neurobehavioral effects of
prenatal exposure to alcohol. Postweaning environmental enrichment can imp
rove behavioral performance and ameliorate or even eliminate deficits in pr
enatal alcohol-exposed rats, although there is persistent impairment in neu
ronal plasticity, as indicated by the failure of hippocampal pyramidal cell
s to increase dendrite spine density. Behavioral and neural responses to CN
S stimulants differ in rats exposed prenatally to alcohol, although it is n
ot clear that these shifts in dose-response curves would predict benefit to
children. Although the present results may sound a note of optimism for th
e development of effective treatment strategies for children with FAS or AR
NDs, it is important to consider that application of these findings in rode
nts may not be straightforward We also need to know the critical features o
f specific environments that influence brain development, and the limits of
pharmacotherapy, as well as critical periods of exposure. Continued study
of the beneficial, ameliorative effects of environmental enrichment, rehabi
litative training, and of pharmacological therapies in animal models, will
remain a valuable source of information for eventually devising treatments
specific for children with FAS and ARNDs. (C) 1999 Elsevier Science Inc. Al
l rights reserved.